2-(n-myristoylamino)-1-phenyl-1-propanol and Malignant Melanoma

2-(n-myristoylamino)-1-phenyl-1-propanol has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bektas, M; Bielawska, A; Eberle, J; Geilen, CC; Goltz, G; Hannun, YA; Hossini, AM; Orfanos, CE; Raisova, M; Riebeling, C	1

Other Studies

1 other study(ies) available for 2-(n-myristoylamino)-1-phenyl-1-propanol and Malignant Melanoma

Article	Year
Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS letters, 2002, Apr-10, Volume: 516, Issue:1-3 Topics: Acid Ceramidase; Amidohydrolases; Apoptosis; Cell Division; Cell Line; Ceramidases; Ceramides; Enzyme Inhibitors; Gene Expression; Genes, bcl-2; Humans; Keratinocytes; Melanoma; Myristates; Propanolamines; Tumor Cells, Cultured	2002

Article

Year

Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.

FEBS letters, 2002, Apr-10, Volume: 516, Issue:1-3

Topics: Acid Ceramidase; Amidohydrolases; Apoptosis; Cell Division; Cell Line; Ceramidases; Ceramides; Enzyme Inhibitors; Gene Expression; Genes, bcl-2; Humans; Keratinocytes; Melanoma; Myristates; Propanolamines; Tumor Cells, Cultured

2002